Results 231 to 240 of about 412,177 (358)

Acquired whole-lung mismatched perfusion defects on pulmonary ventilation/perfusion scintigraphy [PDF]

, 2018
Alberg, Holmes, Pickhardt, Raghu, Rossi, Saad, Slonim, Sostman   +7 more
core   +2 more sources

Performance of an Idiopathic Pulmonary Fibrosis Derived Multibiomarker Panel for Rheumatoid Arthritis‐Associated Interstitial Lung Disease

Arthritis &Rheumatology, Accepted Article.
Objective To assess whether a panel of peripheral blood biomarkers associated with idiopathic pulmonary fibrosis (IPF) is also associated with interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) utilizing three independent cohorts.
Brent A. Luedders, Daniel Kass, Joshua F. Baker, Michael J. Duryee, Yangyuna Yang, Punyasha Roul, Halie Frideres, Katherine D. Wysham, Paul A. Monach, Andreas Reimold, Gail S. Kerr, Gary Kunkel, Grant W. Cannon, Scott M. Matson, Jill A. Poole, Geoffrey M. Thiele, Ted R. Mikuls, Bryant R. England, Dana P. Ascherman   +18 more
wiley   +1 more source

Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis

Arthritis &Rheumatology, Accepted Article.
Objective Peripheral blood leukocyte telomere length (PBL‐TL) shortening is associated with systemic sclerosis related interstitial lung disease (SSc‐ILD). However, its association with other organ involvement, disease severity, and survival remains unclear.
Monica M. Yang, Shuo Liu, Michael Wax II, Seoyeon Lee, Sarah French, Paul J. Wolters, Francesco Boin   +6 more
wiley   +1 more source

Neutrophil-dependent and eosinophil-depedent chemiluminescence to phorbol myristate and opsonized zymosan with pooled human IgG in the patients with infectious diseases, pulmonary fibrosis, hypersensitivity pneumonitis and eosinophilia.

, 1988
Osamu Kohashi, Yukiko Kohashi, Maki Shibata, Syuichi Hashimoto, Maki Tomooka, Hiroko Takahashi, Minako Imamura, Nobuaki Shigematsu   +7 more
openalex   +2 more sources

Evaluation of large language model-generated medical information on idiopathic pulmonary fibrosis. [PDF]

Front Artif Intell
Cherrez-Ojeda I, Frye BC, Hoheisel A, Cortes-Telles A, Robles-Velasco K, Mateos-Toledo HN, Figueiredo RG, Ryerson CJ, Rodas-Valero G, Calderón JC.   +9 more
europepmc   +1 more source

Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]

, 2008
Jimenez, Sergio A., Rosenbloom, Joel
core   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

British Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki, Kiplin A. Patanwala, Jan‐Willem C. Alffenaar, Asad E. Patanwala   +3 more
wiley   +1 more source

Viruses and idiopathic pulmonary fibrosis [PDF]

, 1997
JJ Egan, Ashley Woodcock, James P. Stewart   +2 more
openalex   +1 more source

Establishment of a humanized mouse model of pulmonary fibrosis for advancing drug validation strategies. [PDF]

Sci Rep
Hasan MN, Chae Y, Lee SY, Kang YM.
europepmc   +1 more source

Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series

British Journal of Clinical Pharmacology, EarlyView.
Tacrolimus is a cornerstone immunosuppressant in transplantation medicine with a narrow therapeutic window. Drug–drug interactions with strong CYP3A4 and P‐glycoprotein modulators, such as rifampin and azole antifungals, significantly alter tacrolimus exposure and complicate therapy. Two transplant cases illustrates the impact of rifampin on tacrolimus
Jeroen P. A. Houwen, Aurelia H. M. de Vries Schultink, Bas J. M. Peters, Dieuwertje Ruigrok, Rob H. J. Schönwetter, Esther V. Uijtendaal, Maaike A. Sikma   +6 more
wiley   +1 more source